The boards and health trusts will respond through their local plans to the quality statement. We, of course, will steer the development of those plans and also monitor the development. The Wales Cancer Network board will support the health boards with the pathways that work most effectively on a national level—those that need to be adopted. They will also assist health boards in drawing the data down to deliver services and bring them together. These national pathways are included in the quality statement and many of the service specifications have been included already.

We've already announced that around £100 million is to be invested in imaging equipment—equipment such as CT, MRI and PET/CT scanners. This is a huge investment, and to support this investment, there will be more training placements available for radiologists and radiographers. This is all possible thanks to our imaging academy. We have significantly increased the number of our training placements in oncology. This is also the case in related specialist areas that treat people who have cancer, such as urology and gastroenterology. There is more work still to be done in terms of cancer workforce planning and diagnostics, but the work is already under way through the relevant national plans.

We will invest almost £6.5 million in a new cancer information system. This is a very ambitious programme of work that touches upon every health board and trust. We want to introduce a robust integrated patient record for people affected by cancer. We are investing millions in new linear accelerators. These are devices that provide radiotherapy treatment. In addition to that, we are progressing with the development of a new cancer centre in the south-east of Wales and the possibility of establishing a sub-centre in the area for radiotherapy in order to increase access.

Next year, we will also introduce a new framework for health and social care outcomes and a health service delivery framework. As soon as the final agreement is in place, we will update the quality statement with the relevant targets and metrics on cancer. The Wales Cancer Network board will be part of the NHS executive. This will ensure that in the future, this agenda will benefit from the support of leaders working at a very high level and that all parts of the system will work in a more integrated manner. This is a very ambitious agenda—an agenda that I am confident will help mitigate the impact of the pandemic and allow us to improve outcomes for patients once again.